EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality

Shuhuang Lin, Zhuo Wang, Mingzhao Xing iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Shuhuang Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid Research Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Training Program of Science and Technology Innovation Cultivation Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The clinical relevance of the well-known association between thyroid cancer (TC) and breast cancer (BC) remains to be further defined.

Objective

This work aimed to investigate the effect of history of BC on the prognosis of TC.

Methods

This was a comparative cohort study of tumor behaviors and TC-specific mortality in 5598 patients with papillary thyroid cancer (PTC) and 604 patients with follicular thyroid cancer (FTC), all with a history of BC (TC-BC patients), and their propensity score–matched TC patients without a history of BC (TCnoBC patients) in Surveillance, Epidemiology and End Results (SEER) 18. The main outcome measure was TC-specific mortality.

Results

Lower TC distant metastasis rates of 2.4% vs 3.0% in PTC and 6.1% vs 9.1% in FTC and TC-specific mortality rates of 1.3% vs 2.6% in PTC and 5.8% vs 8.4% in FTC were found in TC-BC patients vs matched TCnoBC patients (all P < .05). Comparing TC-BC patients with matched TCnoBC patients, hazard ratios (HRs) for mortality were 0.472 (95% CI, 0.370-0.601) in PTC and 0.656 (95% CI, 0.461-0.934) in FTC (all P < .05). Such HRs for mortality in PTC were 0.397 (95% CI, 0.268-0.588; P < .001) when TC occurred before BC vs 0.607 (95% CI, 0.445-0.827; P = .002) when BC occurred before TC.

Conclusion

This study demonstrates a robust protective effect of a history of BC on TC-specific patient survival, which has strong implications for more precise prognostication of TC in such patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, PapillaryThyroid NeoplasmsAdenocarcinoma, FollicularHumansFemaleCohort StudiesThyroid Cancer, PapillaryPrognosisRetrospective Studies

Stichwörter der Autor:innen

breast cancermortalityprognosisthyroid cancer

Autor:innen und Institutionen

  • Thyroid Research Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.

ORCID-Profile: Mingzhao Xing

Förderung

  • Guangdong Training Program of Science and Technology Innovation Cultivation Special Fund

Zitieren

APA

Lin, S., Wang, Z., & Xing, M. (2024). Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad722

Vancouver

Lin S, Wang Z, Xing M. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad722

BibTeX
@article{Lin2024,
  author = {Lin, Shuhuang and Wang, Zhuo and Xing, Mingzhao},
  title = {Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad722}
}
Kostenlos starten →